Mutual Of America Capital Management LLC Harmony Biosciences Holdings, Inc. Transaction History

Mutual Of America Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$30.5 - $37.4 $178,608 - $219,014	5,856 New	5,856 $206,000
Q4 2022 Feb 10, 2023	BUY	$45.4 - $60.91 $15,027 - $20,161	331 Added 5.62%	6,216 $342,000
Q3 2022 Nov 08, 2022	BUY	$42.06 - $55.45 $84,877 - $111,898	2,018 Added 52.19%	5,885 $261,000
Q2 2022 Aug 10, 2022	BUY	$33.54 - $52.15 $19,520 - $30,351	582 Added 17.72%	3,867 $189,000
Q1 2022 May 02, 2022	BUY	$33.14 - $51.13 $5,633 - $8,692	170 Added 5.46%	3,285 $160,000
Q4 2021 Feb 03, 2022	BUY	$34.09 - $43.91 $106,190 - $136,779	3,115 New	3,115 $133,000

242

45.1M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.02B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mutual Of America Capital Management LLC with notifications on news.